Partners

Consortium composition: geographic spread, internationalisation and multisectoriality

TRANSLINK is a consortium of 13 partners representing 7 countries (5 EU Member States, 1 from US and 1 associated country).

This current group of partners includes:

  • 6 academic research organisations (INSERM, IBIDELL, UCL, TAU, UGOT, UCal), with expertise scientific research and innovation in the biological and biomedical sciences
  • 4 hospitals and/or clinical practitioners (AOP, CHU, ICS and UNIPD), with expertise in translating research results in a clinical context and testing their efficacy
  • 3 small and medium enterprises (AVT, IUCT and MtB), which are high-technology innovation companies, with expertise in the genetic engineering of farm animals, chemicals and pharmaceuticals, respectively

Many of the publications appearing in the References Section of this document originate from members of this consortium and illustrate the scientific quality of the partnership and their ability to shape the scientific and technological landscape.

The partners involved in the consortium are the one listed below.

01 AOP

AZIENDA OSPEDALIERA DI PADOVA (AOP)

02 imserm 01

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)

03 CHU

CENTRE HOSPITALIER UNIVERSITAIRE DE NANTES (CHU)

04 ics hdb

ICS BELLVITGE UNIVERSITY HOSPITAL (HUB)

04 ICS vdh

ICS VALL D´HEBRON UNIVERSITY HOSPITAL (HUVB)

05 IDIBELL

FUNDACIÓ INSTITUT D’INVESTIGACIÓ BIOMÈDICA DE BELLVITGE (IDIBELL)

06 UCL

UNIVERSITY COLLEGE LONDON (UCL)

07 TAU

TELAVIV UNIVERSITY (TAU)

08 UGOT

GOETEBORGS UNIVERSITET (UGOT)

09 AVT

AVANTEA

Dr. Josep Castells:Maquetaci—n 1

INKEMIA- IUCT GROUP

11

UNIVERSITA DEGLI STUDI DI PADOVA (UNIPD)

12 MtB

MIND THE BYTE

13 UCal

THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (Ucal)